These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11906348)

  • 1. Anaphylaxis to celecoxib.
    Grob M; Pichler WJ; Wüthrich B
    Allergy; 2002 Mar; 57(3):264-5. PubMed ID: 11906348
    [No Abstract]   [Full Text] [Related]  

  • 2. Celecoxib and rofecoxib.
    Brinker AD; Bonnel RA; Feight AG; Nourjah P
    J Am Dent Assoc; 2001 Nov; 132(11):1502, 1504. PubMed ID: 11806062
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective celecoxib-associated anaphylactoid reaction.
    Gagnon R; Julien M; Gold P
    J Allergy Clin Immunol; 2003 Jun; 111(6):1404-5. PubMed ID: 12789245
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug Points: Cholestatic hepatitis in association with celecoxib.
    O'Beirne JP; Cairns SR
    BMJ; 2001 Jul; 323(7303):23. PubMed ID: 11440939
    [No Abstract]   [Full Text] [Related]  

  • 5. Celecoxib- and rofecoxib-induced delirium.
    Macknight C; Rojas-Fernandez CH
    J Neuropsychiatry Clin Neurosci; 2001; 13(2):305-6. PubMed ID: 11449042
    [No Abstract]   [Full Text] [Related]  

  • 6. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.
    Wright JM; Perry TL; Bassett KL; Chambers GK
    JAMA; 2001 Nov; 286(19):2398-400. PubMed ID: 11712925
    [No Abstract]   [Full Text] [Related]  

  • 7. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.
    Hrachovec JB; Mora M
    JAMA; 2001 Nov; 286(19):2398; author reply 2399-400. PubMed ID: 11712924
    [No Abstract]   [Full Text] [Related]  

  • 8. Gastropathy due to celecoxib, a cyclooxygenase-2 inhibitor.
    Mohammed S; Croom DW
    N Engl J Med; 1999 Jun; 340(25):2005-6. PubMed ID: 10383283
    [No Abstract]   [Full Text] [Related]  

  • 9. Pain management in patients with osteoarthritis.
    Finucane TE
    JAMA; 2003 Jul; 290(1):36; author reply 36. PubMed ID: 12837705
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
    Palmer RH
    JAMA; 2000 Apr; 283(15):1961-2. PubMed ID: 10789662
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
    Fernandez H; Lesser GT
    JAMA; 2000 Apr; 283(15):1961; author reply 1962. PubMed ID: 10789661
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclooxygenase 2 selective inhibitor induced bowel stricture: a case report.
    Mir O; Dhote R; Scavennec R; Ropert S; Christoforov B
    Gut; 2004 Jan; 53(1):154. PubMed ID: 14684594
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperkalemia and celecoxib].
    Rego MJ; Fonseré N; Martí S; Rey-Joly C
    Med Clin (Barc); 2002 Jun; 119(1):36-7. PubMed ID: 12062005
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute hepatocellular and cholestatic injury in a patient taking celecoxib.
    Nachimuthu S; Volfinzon L; Gopal L
    Postgrad Med J; 2001 Aug; 77(910):548-50. PubMed ID: 11470953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib-induced acute pancreatitis and hepatitis: a case report.
    Carrillo-Jimenez R; Nurnberger M
    Arch Intern Med; 2000 Feb; 160(4):553-4. PubMed ID: 10695699
    [No Abstract]   [Full Text] [Related]  

  • 16. Summaries for patients. Cyclooxygenase-2 inhibitors and heart attacks: varying effects?
    Ann Intern Med; 2005 Feb; 142(3):I21. PubMed ID: 15684199
    [No Abstract]   [Full Text] [Related]  

  • 17. Celecoxib approved as NSAID with some concessions on class warning.
    Miller JL
    Am J Health Syst Pharm; 1999 Mar; 56(5):403. PubMed ID: 10096694
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular events and COX-2 inhibitors.
    Fleming M
    JAMA; 2001 Dec; 286(22):2808; author reply 2811-2. PubMed ID: 11735742
    [No Abstract]   [Full Text] [Related]  

  • 19. Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group.
    Dahlén B; Szczeklik A; Murray JJ;
    N Engl J Med; 2001 Jan; 344(2):142. PubMed ID: 11188419
    [No Abstract]   [Full Text] [Related]  

  • 20. Balancing the risks and benefits of celecoxib.
    Caldwell B; Beasley R; Weatherall M; Metcalfe S
    Am J Med; 2007 Jun; 120(6):e17. PubMed ID: 17524734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.